Aprogen pharmaceuticals,Inc.

KSE 003060.KS

Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) for the year ending December 31, 2023: 83,224,767

Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) is 83,224,767 for the year ending December 31, 2023, a 55.12% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 53,651,769, a 0.64% change year over year.
Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 53,310,584, a 26.01% change year over year.
Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 42,307,354, a -77.14% change year over year.
Aprogen pharmaceuticals,Inc. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 185,082,516, a 22.32% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

KSE: 003060.KS

Aprogen pharmaceuticals,Inc.

CEO	Mr. Jeong-Chool Kim
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	Halla Sigma Valley 442-2
Employees	377
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years